Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 492849Generated: October 28, 2026

HCID 57677677, compound → HCID 86602167, compound

https://huagongshe.com/reaction/492849

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHCID 57677677HCID 57677677—
CatalystHCID 178418390HCID 178418390—
SolventTetrahydrofuranHCID 8028—
ProductHCID 86602167HCID 86602167—

Reaction Steps

After adding 10% palladium-carbon (21.2 mg) to a solution of benzyl (4-{2-[(4-dimethylaminopiperidine-1-carbonyl)amino]pyridin-4-yloxy}-2-fluorophenyl)carbamate (101 mg) in tetrahydrofuran (10 ml), the mixture was stirred for 16 hours at room temperature under a hydrogen atmosphere. The catalyst was filtered and washed with tetrahydrofuran (4 ml) to provide a solution of 4-dimethylaminopiperidine-1-carboxylic acid [4-(4-amino-3-fluorophenoxy)pyridin-2-yl]amide in tetrahydrofuran (14 ml). A 7 ml portion thereof was concentrated to almost dryness. A solution of 2-phenylacetyl isothiocyanate (26.4 mg) in toluene (3.0 ml) was added to a solution of the residue in ethanol (3.0 ml) at room temperature, and the mixture was stirred for 2 hours at room temperature. The reaction mixture was partitioned between ethyl acetate (60 ml) and saturated aqueous sodium hydrogencarbonate (30 ml). The organic layer was washed with brine and dried over anhydrous sodium sulfate. The organic layer was then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (Fuji Silysia NH, eluent; ethyl acetate, then ethyl acetate:methanol 20:1). The obtained solid was suspended in hexane and filtered. It was then washed with hexane. It was subsequently purified by LC-MS (eluent; acetonitrile-water-trifluoroacetic acid system). Fractions containing the target compound were concentrated, and then the residue was partitioned between saturated aqueous sodium hydrogencarbonate and ethyl acetate. The organic layer was dried over anhydrous sodium sulfate. The organic layer was then concentrated to provide the title compound (8.4 mg) as white powder.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07531532B2
Source datasetuspto-grants-2009_05
ORD IDord-a63c8a7beb1b4c8c948a26a23452d4f2
Source noteuspto-grants-2009_05